Best Wellness Center in Virginia:
If you’ve been researching TRT and cholesterol or wondering whether testosterone therapy will move your blood sugar numbers one way or the other, you’re asking a smarter question than most people think to ask before starting treatment. Cholesterol and blood sugar are two of the most closely watched markers in any bloodwork panel, and it’s reasonable to want to know how a hormone therapy might affect them before committing to it. This article breaks down what testosterone replacement therapy actually does to these two metabolic markers, based on clinical research rather than assumption. For a broader look at how testosterone replacement therapy works overall, that’s a good starting point before diving into the metabolic details below.
Low testosterone rarely shows up in isolation. Men who come in with fatigue, reduced muscle mass, or low libido often also carry some combination of higher body fat, elevated blood sugar, or an unfavorable cholesterol panel. That overlap is not a coincidence, and it’s exactly why so many men ask whether treating low testosterone might also improve, or worsen, these other numbers.
There’s also a fair amount of conflicting information online. Some sources describe TRT as something close to a metabolic cure-all. Others warn it could raise cholesterol or blood sugar. Neither extreme reflects what the research actually shows, which is more nuanced and worth understanding before you look at your own labs.
Testosterone plays a role in several systems that influence both cholesterol and blood sugar, including:
Research has repeatedly found that low testosterone is associated with a higher prevalence of insulin resistance and metabolic syndrome. One review found that up to half of men with type 2 diabetes also have some degree of hypogonadism, a relationship researchers describe as bidirectional: low testosterone contributes to insulin resistance, and insulin resistance and excess body fat further suppress testosterone production.
That association is well established. What’s less settled is exactly how much treating low testosterone with TRT changes cholesterol and blood sugar in return, which is the more useful question for anyone actually considering treatment.
Several clinical studies have looked specifically at lipid panels before and after testosterone therapy, and the general trend has been favorable, though not universal.
An early controlled study published in the journal Atherosclerosis followed hypogonadal and elderly men over one year of testosterone treatment and found significant reductions in total cholesterol and LDL (“bad”) cholesterol, without a significant drop in HDL (“good”) cholesterol. More recent work has built on this: a longer-term observational study published in the International Journal of Clinical Practice, following 255 testosterone-deficient men for up to five years, found reductions in total cholesterol, LDL, and triglycerides, along with an increase in HDL.
A 2026 systematic review published in Cureus pooling multiple randomized and observational studies reached a similar conclusion: TRT was generally associated with reductions in total cholesterol and LDL, while HDL showed modest increases or stayed stable. The same review noted anti-inflammatory effects, including reductions in inflammatory markers linked to cardiovascular risk.
The consistent pattern across most studies: TRT tends to move total cholesterol and LDL in a favorable direction, with HDL holding steady or improving slightly. That said, results vary by formulation, dose, and how long treatment continues, and not every study shows the same magnitude of change.
The picture for blood sugar is a bit more mixed than the cholesterol data, and it’s worth being upfront about that rather than overstating the benefit.
The same five-year observational study published in the International Journal of Clinical Practice, mentioned above, reported measurable reductions in blood glucose and hemoglobin A1c alongside the lipid improvements. Other research on the underlying biology backs this up in principle: testosterone influences insulin sensitivity and glucose uptake in muscle tissue, and low testosterone is consistently linked to a higher risk of developing type 2 diabetes over time.
However, a more recent 2026 systematic review published in Medical Sciences focused specifically on men with obesity and metabolic disease found the evidence for TRT’s effect on blood sugar and glycemic markers to be far less certain than its effect on lipids. That review concluded that while TRT may improve body composition and insulin resistance markers in carefully selected patients, its effects on blood glucose and HbA1c specifically remain uncertain, and researchers were clear that TRT should not be regarded as a treatment for diabetes or used as a substitute for standard blood sugar management.
In short: low testosterone is associated with worse blood sugar control, and some studies show improvement with treatment, but the evidence isn’t yet strong enough to call TRT a reliable blood sugar treatment on its own.
If you’re already managing high cholesterol, prediabetes, or type 2 diabetes, here’s how this typically plays out in practice:
If cardiovascular risk is a specific concern of yours going into treatment, it’s also worth reading how testosterone and heart health relate more broadly, since cholesterol is only one part of that larger picture.
Men in the Virginia Beach area who want their cholesterol and blood sugar tracked alongside testosterone levels throughout treatment can find both in-person and telehealth monitoring options through TRT in Virginia Beach, VA.
Some studies show reductions in total cholesterol and LDL with TRT alone, but results tend to be stronger and more consistent when treatment is paired with better diet and regular exercise, similar to how body composition improvements work.
Some research shows improvement, particularly over longer treatment periods, but the evidence is less consistent than for cholesterol. TRT should not be used as a replacement for standard diabetes management.
Yes. A complete metabolic panel and lipid panel are typically part of the standard bloodwork before starting treatment, giving a clear baseline to compare against later results.
Low testosterone is strongly associated with insulin resistance, metabolic syndrome, and unfavorable lipid patterns, though it’s one contributing factor among several rather than a sole cause.
Not necessarily, but it should be discussed directly with your provider. TRT can be part of a broader treatment plan for men with metabolic conditions, but it needs to be monitored alongside existing medications and lab values rather than treated as a standalone fix.
The research on TRT and cholesterol is fairly encouraging, with most studies showing reductions in total cholesterol and LDL alongside stable or improved HDL. The picture for blood sugar is more mixed: low testosterone is clearly linked to worse glucose control, and some studies show improvement with treatment, but the evidence isn’t strong enough yet to call TRT a reliable treatment for blood sugar on its own. For most men, the practical takeaway is the same either way: regular bloodwork before and during treatment is what actually answers the question for your specific numbers, rather than a general study average.
Neil Williams, NP brings 24 years of Navy service and clinical experience in emergency and critical care medicine to every evaluation at Alive Total Wellness. A full metabolic and hormone panel is part of every initial consultation, giving you a clear picture of where you stand before starting treatment.
Disclaimer: The information provided in this article is for educational purposes only and is not intended as medical advice. It does not replace the guidance of a qualified healthcare provider. Testosterone Replacement Therapy should only be pursued under the guidance of a licensed medical provider following a comprehensive evaluation and confirmed diagnosis. Individual results and timelines vary. If you are experiencing symptoms described in this article, consult a licensed medical professional before making any decisions about testing or treatment.
